ArticleNeuro-oncology advances

First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastoma.

James R Whittle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.